肌肉注射钴宾酰胺与生理盐水治疗猪重度硫化氢中毒的对比研究
研究在11头45-55 kg麻醉猪中建立重度硫化氢中毒模型,经静脉输注硫氢化钠(8 mg/mL,0.9 mg/kg.min)至呼吸暂停或严重低血压触发,随机给予肌注钴宾酰胺(4 mg/kg)或不治疗。触发后继续输注硫氢化钠1.5 min,再以0.2 mg/kg.min维持10 min后停止。钴宾酰胺组5/5全部存活,对照组0/6存活(p<.01);钴宾酰胺组恢复自主通气平均时间3.2(±1.1)min,收缩压恢复至基线±5%的时间为5 min。作者结论认为肌注钴宾酰胺在该大动物重度硫化氢中毒模型中改善存活。
要点
- 重度硫化氢中毒猪模型触发呼吸暂停或严重低血压后,肌注钴宾酰胺4 mg/kg组5/5存活,未治疗对照组0/6存活(p<.01)。
- 钴宾酰胺组恢复自主通气平均时间3.2(±1.1)min,收缩压恢复至基线±5%的时间为5 min。
- 两组达到触发点所需硫氢化钠量无统计学差异(钴宾酰胺组9.0 mg/kg ±6.1 vs 对照组5.9 mg/kg ±5.5,平均差-3.1,95%CI -11.3至5.0)。
- 目前尚无FDA批准的硫化物中毒解毒剂,作者此前报道静脉钴宾酰胺对硫化物中毒有效,肌注剂型可能适合院前使用。
适用人群与场景
- 11头45-55 kg麻醉、插管并持续监测股动脉和肺动脉压力的猪,在FiO2 0.21下自主通气稳定后建立重度硫化氢中毒模型。
诊断标准与关键阈值
- 以静脉输注硫氢化钠(8 mg/mL,0.9 mg/kg.min)至出现呼吸暂停或严重低血压作为中毒触发点和给药时机。
处置流程与药物剂量
- 在呼吸暂停或严重低血压触发时随机给予肌注钴宾酰胺4 mg/kg或不治疗;触发后硫氢化钠输注速率维持1.5 min,随后降至0.2 mg/kg.min持续10 min后停止。
研究设计与关键结果
- 动物实验:11头猪随机分入肌注钴宾酰胺4 mg/kg组(n=5)或不治疗对照组(n=6),钴宾酰胺组5/5存活,对照组0/6存活(p<.01)。
- 达到呼吸暂停或低血压所需硫氢化钠量:钴宾酰胺组9.0 mg/kg ±6.1 vs 对照组5.9 mg/kg ±5.5,平均差-3.1(95%CI -11.3至5.0),无统计学差异。
- 钴宾酰胺组恢复自主通气平均时间3.2(±1.1)min,收缩压恢复至基线±5%的时间为5 min。
证据类型、等级与局限
- 证据类型:动物实验(大动物猪模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为肌注钴宾酰胺在该大动物重度硫化氢中毒模型中改善存活,提示其可能适合院前场景使用,但尚需进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Hydrogen sulfide (H2S) is found in petroleum, natural gas, and decaying organic matter. Terrorist groups have attempted to use it in enclosed spaces as a chemical weapon. Mass casualty scenarios have occurred from industrial accidents and release from oil field sites. There is no FDA approved antidote for sulfide poisoning. We have previously reported that intravenous cobinamide is effective for sulfide poisoning. A rapid-acting antidote that is easy to administer intramuscularly (IM) would be ideal for use in a prehospital setting. In this study, we assessed survival in sulfide-poisoned swine treated with IM cobinamide.
METHODS: Eleven swine (45-55 kg) were anesthetized, intubated, and instrumented with continuous femoral and pulmonary artery pressure monitoring. After stabilization, anesthesia was adjusted such that animals ventilated spontaneously with a FiO2 of 0.21. Sodium hydrosulfide (NaHS, 8 mg/mL) was infused intravenously at 0.9 mg/kg.min until apnea or severe hypotension. Animals were randomly assigned to receive cobinamide (4 mg/kg), or no treatment at the apnea/hypotension trigger. The NaHS infusion rate was sustained for 1.5 min post trigger, decreased to 0.2 mg/kg.min for 10 min, and then discontinued.
RESULTS: The amount of NaHS required to produce apnea or hypotension was not statistically different in both groups (cobinamide: 9.0 mg/kg ±6.1; saline: 5.9 mg/kg ±5.5; mean difference: -3.1, 95% CI: -11.3, 5.0). All of the cobinamide treated animals survived (5/5), none of the control (0/6) animals survived (p < .01). Mean time to return to spontaneous ventilation in the cobinamide treated animals was 3.2 (±1.1) min. Time to return to baseline systolic blood pressure (±5%) in cobinamide-treated animals was 5 min.
CONCLUSION: Intramuscular cobinamide was effective in improving survival in this large swine model of severe hydrogen sulfide toxicity.
参考来源
- Ng PC, Hendry-Hofer TB, Garrett N, et al. Intramuscular cobinamide versus saline for treatment of severe hydrogen sulfide toxicity in swine. Clin Toxicol (Phila). 2018. PMID: 30430872. doi:10.1080/15563650.2018.1504955
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。